Adicet Bio, Inc. Share Price
ACETAdicet Bio, Inc. Stock Performance
Open $7.67 | Prev. Close $7.81 | Circuit Range N/A |
Day Range $7.59 - $7.94 | Year Range $0.46 - $8.83 | Volume 5,948 |
Average Traded $7.69 |
Adicet Bio, Inc. Share Price Chart
About Adicet Bio, Inc.
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States. It offers gamma delta T cells engineered with chimeric antigen receptors (CARs) to facilitate durable activity in patients. The company's lead product candidate is ADI-001, an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, which is in Phase I clinical trial for the potential treatment of autoimmune diseases and relapsed/refractory B-cell non-hodgkin's lymphoma. It also develops ADI-270, an armored gamma delta CAR T cell product candidate to treat multiple CD70+ solid tumor and hematological malignancies indications, with renal cell carcinoma. The company was founded in 2014 and is based in Boston, Massachusetts.
Adicet Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
19-May-26 | $7.38 | $7.26 | -2.55% |
18-May-26 | $7.60 | $7.45 | -3.25% |
15-May-26 | $8.13 | $7.70 | -7.89% |
14-May-26 | $8.13 | $8.36 | +5.16% |
12-May-26 | $7.96 | $7.95 | -2.69% |
11-May-26 | $8.42 | $8.17 | -4.44% |
08-May-26 | $8.59 | $8.55 | +1.73% |